Bone-Derived FGF23 Promotes Tumor Progression and Bone Disease In Multiple Myeloma

被引：0
|
作者：
Anloague, Aric [1 ]
Sabol, Hayley M. [1 ]
Kaur, Japneet [2 ]
Khan, Sharmin [1 ]
Ashby, Cody [2 ,3 ]
Schinke, Carolina [4 ,5 ]
Barnes, C. Lowry [6 ]
Ambrogini, Elena [7 ]
Bellido, Teresita M. [1 ]
Delgado-Calle, Jesus [2 ]
机构：
[1] Univ Arkansas Med Sci, Dept Physiol & Cell Biol, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA
[4] Winthrop P Rockefeller Canc Inst, Little Rock, AR USA
[5] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR 72205 USA
[6] Univ Arkansas Med Sci, Dept Orthoped Surg, Little Rock, AR 72205 USA
[7] Univ Arkansas Med Sci, Div Endocrinol & Metab, Little Rock, AR USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1007
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [41] FGF23, Albuminuria, and Disease Progression in Patients with Chronic IgA Nephropathy
    Lundberg, Sigrid
    Qureshi, Abdul Rashid
    Olivecrona, Sara
    Gunnarsson, Iva
    Jacobson, Stefan H.
    Larsson, Tobias E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (05): : 727 - 734
  • [42] The hypoxic bone marrow microenvironment in multiple myeloma tumor progression.
    Asosingh, K
    De Raeve, H
    de Ridder, M
    Storme, GA
    Willems, A
    Van Riet, I
    Van Camp, B
    Vanderkerken, K
    BLOOD, 2004, 104 (11) : 646A - 646A
  • [43] Increased bone FGF23 production in CKD is associated with altered osteocyte development and bone mineralization.
    Dussold, Corey
    Neuburg, Samantha
    Liu, Ying
    Feng, Jian Q.
    Wang, Xueyan
    David, Valentin
    Wolf, Myles
    Martin, Aline
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S237 - S238
  • [44] Bone Disease in Multiple Myeloma
    Drake, Matthew T.
    ONCOLOGY-NEW YORK, 2009, 23 (14): : 28 - 32
  • [45] Bone disease in multiple myeloma
    Croucher, PI
    Apperley, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) : 902 - 910
  • [46] Bone disease in multiple myeloma
    Hjertner, Oyvind
    Standal, Therese
    Borset, Magne
    Sundan, Anders
    Waage, Anders
    MEDICAL ONCOLOGY, 2006, 23 (04) : 431 - 441
  • [47] FIBROBLAST GROWTH FACTOR-23 PROMOTES OSTEOBLAST DIFFERENTIATION IN BONE-DERIVED MESENCHYMAL STEM CELLS
    He, X.
    Li, Y.
    Olauson, H.
    Lindgren, U.
    Larsson, T. E.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S701 - S702
  • [48] The link between bone-derived factors osteocalcin, fibroblast growth factor 23, sclerostin, lipocalin 2 and tumor bone metastasis
    Martiniakova, Monika
    Mondockova, Vladimira
    Biro, Roman
    Kovacova, Veronika
    Babikova, Martina
    Zemanova, Nina
    Ciernikova, Sona
    Omelka, Radoslav
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [49] FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice
    Sun, Ningyuan
    Guo, Yuchen
    Liu, Weiqing
    Densmore, Michael
    Shalhoub, Victoria
    Erben, Reinhold G.
    Ye, Ling
    Lanske, Beate
    Yuan, Quan
    SCIENTIFIC REPORTS, 2015, 5
  • [50] FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice
    Ningyuan Sun
    Yuchen Guo
    Weiqing Liu
    Michael Densmore
    Victoria Shalhoub
    Reinhold G. Erben
    Ling Ye
    Beate Lanske
    Quan Yuan
    Scientific Reports, 5
12345